Skip to content
10-K

Annual Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-22-000111

← back to feed
Filed
Mar 23, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 23, 2022 708K sh
Operating Cash Flow FY 2021 · Dec 31, 2020 −$8.73K
Cash And Equivalents FY 2021 · Dec 31, 2020 $3.55K
Cash And Equivalents FY 2021 · Dec 31, 2019 $77
Current Liabilities FY 2021 · Dec 31, 2020 $348.69K
Total Liabilities FY 2021 · Dec 31, 2020 $348.69K
Current Assets FY 2021 · Dec 31, 2020 $3.55K
Total Assets FY 2021 · Dec 31, 2020 $3.55K
Eps Basic FY 2021 · Dec 31, 2020 −$0.04
Sga Expense FY 2021 · Dec 31, 2020 $13.53K
Net Income FY 2021 · Dec 31, 2020 −$30.96K
Operating Income FY 2021 · Dec 31, 2020 −$13.53K
Stockholders Equity FY 2021 · Dec 31, 2019 −$314.19K